| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA5314357 | ETARACIZUMAB | Hepatotoxicity (mechanism) | 0 | ALA3137740 | |||||||
| 2. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (time to onset) | 0 | ALA3137739 | |||||||
| 3. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (comment) | 0 | ALA3137738 | |||||||
| 4. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (successful reintroduction) | 0 | ALA3137737 | |||||||
| 5. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (animal toxicity known) | 0 | ALA3137736 | |||||||
| 6. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (benign tumour) | = | 0 | ALA3137735 | references out of a total of 1 | |||||
| 7. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (malignant tumour) | = | 0 | ALA3137734 | references out of a total of 1 | |||||
| 8. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (steatosis) | = | 0 | ALA3137733 | references out of a total of 1 | |||||
| 9. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (association with vascular disease) | = | 0 | ALA3137732 | references out of a total of 1 | |||||
| 10. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (granulomatous hepatitis) | = | 0 | ALA3137731 | references out of a total of 1 | |||||
| 11. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (cirrhosis) | = | 0 | ALA3137730 | references out of a total of 1 | |||||
| 12. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (chronic liver disease) | = | 0 | ALA3137729 | references out of a total of 1 | |||||
| 13. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (severe hepatitis) | = | 0 | ALA3137728 | references out of a total of 1 | |||||
| 14. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (choleostasis) | = | 0 | ALA3137727 | references out of a total of 1 | |||||
| 15. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (cytolytic) | = | 0 | ALA3137726 | references out of a total of 1 | |||||
| 16. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (acute) | = | 0 | % | ALA3137725 | % | ||||
| 17. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (acute) | = | 0 | ALA3137724 | references out of a total of 1 | |||||
| 18. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (moderate) | = | 77.8 | % | ALA3137723 | % | ||||
| 19. | ALA5314357 | ETARACIZUMAB | Hepatotoxicity (moderate) | = | 1 | ALA3137722 | references out of a total of 1 |
The page will load shortly, Thanks for your patience!